Form 4 for CTEV Claritev Corp
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001793229-24-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-01 | CTEV | Dalton Travis | CEO, Dir | A - Grant | $1.11 | +4.50M | 4.50M | New | +$5.00M |
| D | 2024-03-05 | 2024-03-01 | CTEV | Dalton Travis | CEO, Dir | A - Grant | $0.00 | +6.85M | 6.85M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock | 2024-03-01 | A | A | 4,504,504 | $1.11 | 4,504,504 | D | — | — | |
| 2 | Derivative | Stock Option | 2024-03-01 | A | A | 6,849,315 | $0.00 | 6,849,315 | D | $1.11 · — to 2034-03-01 | 6,849,315 Class A common stock | (F2) The grant will vest, and become exercisable, at a rate of one-third per year on each of March 1, 2025, 2026, and 2027. |